Introduction: Varicocele is a common condition affecting up to 15% of men. It is
associated with impaired testicular function due to venous reflux and oxidative
stress. While its role in male infertility is well established, the extent to which it
impacts hormonal function, particularly testosterone production, is still being
debated. The purpose of this review was to evaluate the hormonal outcomes of
varicocelectomy, with a particular focus on differences between hypogonadal and
eugonadal men. To determine whether both groups benefit from the surgery.
Materials and Methods: A literature review was conducted using the PubMed and
Google Scholar databases to identify published studies from 2014 to 2024. Metaanalyses,
systematic reviews, and original studies reporting hormonal parameters
before and after varicocelectomy were included in the analysis. Studies were
selected based on inclusion and exclusion criteria, and hypogonadism was defined
as total testosterone <300 ng/dL, according to AUA guidelines. Results: Twelve
studies (four meta-analyses and eight original articles) were included. Most metaanalyses
and prospective studies showed a significant increase in serum
testosterone levels in hypogonadal men after varicocelectomy. In contrast,
eugonadal men generally showed no significant hormonal changes. Small decreases
in LH and FSH levels were also observed postoperatively, suggesting improved
regulation of the hypothalamic-pituitary-testicular axis. Conclusion: Varicocelectomy
appears to provide endocrine benefits in hypogonadal men with clinically
significant varicoceles and can be considered a therapeutic alternative to
testosterone replacement therapy. In eugonadal men, routine surgery is not
justified. Future research should focus on risk stratification and surveillance
strategies to identify patients with varicocele at risk for progressive Leydig cell
dysfunction.
Keywords: varicocele, varicocelectomy, testosterone, hypogonadism, Leydig cell
function
